What is the recommended Hepatitis B (HB) vaccine dosage for adults?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: July 16, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Hepatitis B Vaccine Dosage for Adults

The recommended hepatitis B vaccine dosage for adults depends on the specific vaccine product, with standard adult dosing being 10-20 μg administered in a series of 2-3 doses depending on the vaccine brand. 1

Standard Adult Dosing by Vaccine Type

Single-Antigen Vaccines

  • Recombivax HB:

    • Adults ≥20 years: 10 μg (1.0 mL) per dose
    • Schedule: 3 doses at 0,1, and 6 months 1
  • Engerix-B:

    • Adults ≥20 years: 20 μg (1.0 mL) per dose
    • Schedule: 3 doses at 0,1, and 6 months 1
  • Heplisav-B:

    • Adults ≥18 years: 20 μg (0.5 mL) per dose
    • Schedule: 2 doses at 0 and 1 month 1
  • PreHevbrio:

    • Adults ≥18 years: 10 μg (1.0 mL) per dose
    • Schedule: 3 doses at 0,1, and 6 months 1

Combination Vaccine

  • Twinrix (Hepatitis A-Hepatitis B):
    • Adults ≥18 years: 20 μg HBsAg (1.0 mL) per dose
    • Standard schedule: 3 doses at 0,1, and 6 months
    • Accelerated schedule: 4 doses at 0,7,21-30 days, and 12 months 1

Special Populations

Hemodialysis Patients and Immunocompromised Adults

  • Recombivax HB: 40 μg (1.0 mL) per dose, 3-dose series 1
  • Engerix-B: 40 μg (2.0 mL) per dose, 4-dose series at 0,1,2, and 6 months 1

Important Considerations for Special Populations

  • Heplisav-B and PreHevbrio have not been established as safe or effective for adults on hemodialysis 1
  • For pregnant women requiring HBV vaccination, providers should use Engerix-B, Recombivax HB, or Twinrix rather than Heplisav-B or PreHevbrio due to insufficient data on vaccine-associated risks in pregnancy 1

Administration Guidelines

  • Administer intramuscularly in the deltoid muscle for adults 1
  • If the vaccination schedule is interrupted, the series does not need to be restarted 1
  • For an interrupted 3-dose series:
    • If interrupted after first dose: Give second dose as soon as possible
    • Second and third doses should be separated by ≥8 weeks
    • Final dose must be administered ≥8 weeks after second dose and ≥16 weeks after first dose 1
  • Minimum interval between first and second doses is 4 weeks 1

Vaccine Response and Efficacy

  • The 3-dose vaccine series produces a protective antibody response in >90% of healthy adults under age 40 1
  • Response rates decline with age:
    • Adults over 40: <90% response rate
    • Adults over 60: approximately 75% response rate 1
  • Other factors affecting response include smoking, obesity, genetic factors, and immune suppression 1

Common Pitfalls to Avoid

  1. Incorrect administration site: Always use deltoid muscle in adults, never the buttock (significantly reduces immunogenicity) 1

  2. Improper dosing for special populations: Hemodialysis patients require higher doses and sometimes additional doses compared to the general population 1

  3. Restarting interrupted series: If a series is interrupted, it doesn't need to be restarted - simply continue where left off 1

  4. Mixing vaccines inappropriately: While completing a series with a different brand is acceptable, certain vaccines (Heplisav-B, PreHevbrio) have specific limitations for certain populations 1

  5. Unnecessary antibody testing: Routine post-vaccination serologic testing is not needed for most healthy adults 1

The Advisory Committee on Immunization Practices now recommends universal hepatitis B vaccination for all adults aged 19-59 years, regardless of risk factors, which removes the need for risk factor screening and could increase vaccination coverage 1.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.